Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
60,673,852
-
Share change
-
+13,377,891
-
Total reported value
-
$664,929,310
-
Put/Call ratio
-
16%
-
Price per share
-
$10.96
-
Number of holders
-
133
-
Value change
-
+$151,136,418
-
Number of buys
-
64
-
Number of sells
-
73
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2017
As of 31 Mar 2017,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,673,852 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, INGALLS & SNYDER LLC, BlackRock Inc., Consonance Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Invesco Ltd., MORGAN STANLEY, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
133
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.